Purpose To compare an iontophoresis riboflavin delivery technique for transepithelial corneal collagen crosslinking (I-CXL) with a conventional CXL (C-CXL). Methods We designed 3 experimental sets using 152 New Zealand rabbits to study riboflavin application by iontophoresis using charged riboflavin solution (Ricrolin+®) with a 1mA current for 5 min. The first set was to compare riboflavin concentration measured by High-Performance Liquid Chromatography (HPLC) in corneas after iontophoresis or conventional riboflavin application. The second set was to analyze autofluorescence and stromal collagen modification immediately and 14 days after I-CXL or C-CXL, by using nonlinear two-photon microscopy (TP) and second harmonic generation (SHG). In the third set, physical modifications after I-CXL and C-CXL were evaluated by stress-strain measurements and by studying corneal resistance against collagenase digestion. Results Based on HPLC analysis, we found that iontophoresis allowed riboflavin diffusion with two-fold less riboflavin concentration than conventional application (936.2 ± 312.5 ng/ml and 1708 ± 908.3 ng/ml, respectively, p<0.05). Corneal TP and SHG imaging revealed that I-CXL and C-CXL resulted in a comparable increased anterior and median stromal autofluorescence and collagen packing. The stress at 10% strain showed a similar stiffness of corneas treated by I-CXL or C-CXL (631.9 ±241.5 kPa and 680.3 ±216.4 kPa, respectively, p=0.908). Moreover, we observed an increased resistance against corneal collagenase digestion after I-CXL and C-CXL (61.90 ±5.28 % and 72.21 ±4.32 % of remaining surface, respectively, p=0.154). Conclusions This experimental study suggests that I-CXL is a promising alternative methodology for riboflavin delivery in crosslinking treatments, preserving the epithelium.